Bank of America raised its Humana price target to $330 (Neutral) after UnitedHealth's strong Medicare Advantage Star Ratings update, while Raymond James called the pullback a buying opportunity, reaffirming 'Outperform'. Analysts warned 2027 rate uncertainty could delay earnings recovery. Retail sentiment turned 'extremely bullish'.